The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients

Terada, Naoki; Kamoto, Toshiyuki; Tsukino, Hiromasa; Mukai, Shoichiro; Akamatsu, Shusuke; Inoue, Takahiro; Ogawa, Osamu; Narita, Shintaro; Habuchi, Tomonori; Yamashita, Shinichi; Mitsuzuka, Koji; Arai, Yoichi; Kandori, Shuya; Kojima, Takahiro; Nishiyama, Hiroyuki; Kawamura, Yoshiaki; Shimizu, Yuki; Terachi, Toshiro; Sugi, Motohiko; Kinoshita, Hidefumi; Matsuda, Tadashi; Yamada, Yusuke; Yamamoto, Shingo; Hirama, Hiromi; Sugimoto, Mikio; Kakehi, Yoshiyuki; Sakurai, Toshihiko; Tsuchiya, Norihiko

doi:10.1186/s12885-019-5342-9

BMC Cancer

Article metrics
Last updated: Fri, 26 Apr 2024 9:53:02 Z

The efficacy and toxicity of cabazitaxel for treatment of docetaxel-resistant prostate cancer correlating with the initial doses in Japanese patients

Access & Citations

6470

Article Accesses
10

Web of Science
11

CrossRef

Citation counts are provided from Web of Science and CrossRef. The counts may vary by service, and are reliant on the availability of their data. Counts will update daily once available.

ISSN: 1471-2407

Contact us

Submission enquiries: bmccancer@biomedcentral.com
General enquiries: ORSupport@springernature.com